Detection of peptide-based nanoparticles in blood plasma by ELISA
Autor/a
Altres autors/es
Data de publicació
2015-05Resum
Aims
The aim of the current study was to develop a method to detect peptide-linked nanoparticles in blood plasma.
Materials & Methods
A convenient enzyme linked immunosorbent assay (ELISA) was developed for the detection of peptides functionalized with biotin and fluorescein groups. As a proof of principle, polymerized pentafluorophenyl methacrylate nanoparticles linked to biotin-carboxyfluorescein labeled peptides were intravenously injected in Wistar rats. Serial blood plasma samples were analyzed by ELISA and by liquid chromatography mass spectrometry (LC/MS) technology.
Results
The ELISA based method for the detection of FITC labeled peptides had a detection limit of 1 ng/mL.We were able to accurately measure peptides bound to pentafluorophenyl methacrylate nanoparticles in blood plasma of rats, and similar results were obtained by LC/MS.
Conclusions
We detected FITC-labeled peptides on pentafluorophenyl methacrylate nanoparticles after injection in vivo. This method can be extended to detect nanoparticles with different chemical compositions.
Tipus de document
Article
Versió publicada
Llengua
Anglès
Matèries (CDU)
539 - Constitució física de la matèria
Paraules clau
Nanopartícules
Plasma sanguini
Enzimoimmunoassaig
Injeccions intravenoses
Cromatografia de líquids
Espectrometria de masses
Nanoparticles
Blood plasma
Biotin
Enzyme-linked immunoassays
Wistar rats
Acrylics
Intravenous injections
Liquid chromatography-mass spectrometry
Pàgines
12 p.
Publicat per
Public Library of Science (PLoS)
Publicat a
PLoS ONE. Vol.10, n.5 (2015), e0126136
Aquest element apareix en la col·lecció o col·leccions següent(s)
Drets
© L'autor/a
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by/4.0/